Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 352 across all filing types
Latest filing 2020-11-13 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 텔콘알에프제약' covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial statements, notes to financial statements, management discussion and analysis, and other corporate governance information required for a quarterly filing. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS). This type of filing is a standard regulatory disclosure required when a major shareholder or executive changes their stake in a company. In the context of the provided categories, this falls under 'Major Shareholding Notification' (MRQ) as it details the change in ownership percentage and specific securities held by a major shareholder (Hanil Vacuum).
2020-11-09 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korea Exchange regarding the decision to issue convertible bonds (전환사채권 발행결정). It includes detailed terms of the issuance, such as interest rates, conversion prices, and the purpose of the funds. This type of regulatory filing in the Korean market, which details capital structure changes and financing activities, is classified as a Capital/Financing Update.
2020-11-09 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the decision to issue convertible bonds (전환사채권 발행결정) by Telcon RF Pharmaceutical. It includes detailed terms of the issuance, such as interest rates, conversion prices, put options, and the purpose of the funds. This type of filing is a formal regulatory disclosure regarding capital structure changes and financing activities, which falls under the 'Capital/Financing Update' category.
2020-11-09 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding the decision to issue convertible bonds (전환사채권 발행결정). It includes detailed terms of the issuance, such as interest rates, conversion prices, and the purpose of the funds. This falls under the category of capital and financing updates, as it details the company's fundraising activities through debt instruments.
2020-11-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including convertible bonds and special relationships, for the company Telcon RF Pharmaceutical. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-11-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.